查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1796521

全球克隆氏症藥物市場報告：趨勢、預測和競爭分析（至2031年）

Crohn's Disease Treatment Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球克隆氏症藥物市場前景光明，小腸和大腸市場都蘊藏著機會。預計2025年至2031年期間，全球克隆氏症藥物市場規模將以3.8%的年複合成長率成長。該市場的主要驅動力包括：全球克隆氏症的上升、治療需求的增加、持續的藥物研發以帶來更有效的治療方案，以及認知度和診斷水準的提高，促進治療方案的採用。

  • Lucintel 預測，由於免疫調節藥物具有針對性的作用和日益普及的採用率，預計在預測期內，免疫調節藥物將實現高速成長。
  • 在應用方面，小腸預計將出現最高的成長，因為它是克隆氏症最常影響的區域。
  • 依地區分類，北美預計將在預測期內實現最高成長，因為它擁有強大的醫療保健基礎設施和認知度。

克隆氏症治療市場的新趨勢

生物療法、精準醫療和新治療方案等新興趨勢改變克隆氏症藥物市場，改善患者預後、最佳化治療並擴大治療機會。

  • 生物製藥：抗腫瘤壞死因子抑制劑、抗整合素療法和白細胞介素抑制劑是治療中度至重度克隆氏症的快速成長的藥物。生物製藥比傳統藥物更具特異性和效力，副作用較少，疾病控制效果較好。生物製藥也推動市場成長。
  • 口服藥物：克隆氏症口服治療的引進，透過提供更方便的選擇，徹底改變患者的治療方案。 JAK抑制劑等口服藥物減少了注射需求，並提高了患者的依從性和生活品質。這一趨勢可望推動市場成長，尤其是在尋求更容易管理治療方法的患者群體中。
  • 個人化醫療：精準醫療是一種新興趨勢，它根據患者的基因圖譜和疾病特徵量身訂做治療方案。識別特定的生物標記物使醫生能夠個性化克隆氏症的治療，改善療效並減少副作用。這種方法可能會對克隆氏症的治療方法產生重大影響。
  • 生物相似藥：隨著生物製藥應用的不斷擴大，生物相似藥的開發已成為治療克隆氏症的一種經濟有效的解決方案。生物相似藥是品牌生物製藥的替代品，價格更實惠，有望改善患者獲得優質醫療服務的管道，尤其是在醫療預算有限的新興市場。
  • 遠端醫療和遠端監控：遠端醫療和遠端患者監護在克隆氏症治療市場中日益普及。這些技術使醫療保健提供者能夠遠端追蹤患者的症狀和治療依從性，改善疾病管理。遠端醫療可以實現更好的後續護理，並及時調整治療方法，改善患者的治療效果。

生物製藥、口服藥物、個人化醫療、生物相似藥和遠端醫療等新興趨勢顛覆克隆氏症藥物市場。這些創新豐富治療選擇，改善患者預後，擴大醫療服務可近性，並重塑全球克隆氏症的治療模式。

克隆氏症病藥物市場的最新發展

克隆氏症治療市場近期呈現顯著趨勢，這主要得益於生物製藥、口服藥物和診斷技術的創新。這些發展有助於提高疾病管理的有效性，並為患者和製藥公司創造重大機會。

  • 新型生物製藥核准：多種新型生物製藥已核准用於治療克隆氏症，為中度至重度克隆氏症症患者提供更有針對性、更有效的治療。這些藥物針對特定的發炎通路，與傳統治療方法相比，可更佳控制病情並減少副作用。
  • 口服JAK抑制劑的推出：口服Janus激酶（JAK）抑制劑（用於治療克隆氏症）的核准和上市，改變了治療格局。這些口服藥物為注射用生物製藥提供了替代方案，使患者的治療更輕鬆便捷，提高了依從性和整體治療效果。
  • 生物相似藥與成本降低：生物相似藥的發展使生物製藥治療更經濟實惠，患者也更容易取得。生物相似藥的推出有助於克隆氏症治療市場的擴張，因為它減輕了患者成本負擔，使更多患者能夠從生物製藥中受益。
  • 先進的診斷工具：生物標記和先進的影像技術等新型診斷工具改善克隆氏症的診斷和監測。這些進步使得更早發現疾病並更準確地監測其進展成為可能，改善療效並實現個人化治療。
  • 關注個人化醫療：個人化醫療是指根據個別基因組成和疾病特徵制定個人化治療方案，在克隆氏症的治療中日益受到重視。利用基因檢測來確定治療方案，有可能改善療效並減少副作用。

克隆氏症治療市場的最新發展，包括新型生物製藥、口服JAK抑制劑、生物相似藥、先進診斷技術和個人化醫療，重塑治療格局。這些創新改善患者照護，並為克隆氏症的治療提供更有針對性、更便捷、更具成本效益的選擇。

目錄

第1章 執行摘要

第2章 市場概述

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 克隆氏症藥物市場（依類型）

  • 概述
  • 依類型的吸引力分析
  • 氨基水楊酸鹽：趨勢與預測（2019-2031）
  • 皮質類固醇：趨勢與預測（2019-2031）
  • 免疫調節藥物：趨勢與預測（2019-2031）
  • 抗生素：趨勢與預測（2019-2031）

第5章 克隆氏症治療藥物市場（依應用）

  • 概述
  • 依用途的吸引力分析
  • 小腸：趨勢與預測（2019-2031）
  • 大腸直腸疾病：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 克隆氏症治療市場（依地區）

第7章 北美克隆氏症藥物市場

  • 概述
  • 北美克隆氏症治療市場（依類型）
  • 北美克隆氏症治療市場（依應用）
  • 美國克隆氏症治療市場
  • 墨西哥克隆氏症治療市場
  • 加拿大克隆氏症藥物市場

第8章 歐洲克隆氏症藥物市場

  • 概述
  • 歐洲克隆氏症治療市場（依類型）
  • 歐洲克隆氏症治療市場（依應用）
  • 德國克隆氏症藥物市場
  • 法國克隆氏症治療市場
  • 西班牙克隆氏症治療市場
  • 義大利克隆氏症藥物市場
  • 英國克隆氏症藥物市場

第9章 亞太克克隆氏症藥物市場

  • 概述
  • 亞太克隆氏症藥物市場（依類型）
  • 亞太克隆氏症治療市場（依應用）
  • 日本克隆氏症治療市場
  • 印度克隆氏症治療市場
  • 中國克隆氏症治療市場
  • 韓國克隆氏症治療市場
  • 印尼的克隆氏症治療市場

第10章 世界其他地區克隆氏症症治療市場

  • 概述
  • 世界其他地區克隆氏症症藥物市場（依類型）
  • 世界其他地區克隆氏症症藥物市場（依應用）
  • 中東克隆氏症治療市場
  • 南美洲克隆氏症治療市場
  • 非洲克隆氏症治療市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 克隆氏症治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業概況

  • 競爭分析
  • Biogen
  • UCB
  • Boehringer
  • AstraZeneca
  • AbbVie

第14章 附錄

  • 圖表一覽
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global Crohn's disease treatment drug market looks promising with opportunities in the small intestine and large intestine markets. The global Crohn's disease treatment drug market is expected to grow with a CAGR of 3.8% from 2025 to 2031. The major drivers for this market are the rising prevalence of Crohn's disease globally, which increases demand for treatment, advancements in drug development that lead to more effective therapies, and increased awareness and diagnosis that drive higher adoption of treatment options.

  • Lucintel forecasts that, within the type category, immunomodulators are expected to witness higher growth over the forecast period due to their targeted action and increasing adoption.
  • Within the application category, the small intestine is expected to witness the highest growth due to more frequent involvement in Crohn's disease.
  • In terms of region, North America is expected to witness the highest growth over the forecast period due to advanced healthcare infrastructure and awareness.

Emerging Trends in the Crohn's Disease Treatment Drug Market

Emerging trends such as biologic therapies, precision medicine, and new treatment options are changing the Crohn's disease treatment drug market. These emerging trends are shaping the market in terms of improving patient outcomes, optimizing treatments, and expanding access to medications.

  • Biologics: Anti-TNF inhibitors, anti-integrin therapies, and interleukin inhibitors are a fast-growing treatment avenue for moderate to severe Crohn's disease. Biologics are more specific and more potent than conventional drugs; thus, they help patients with fewer side effects and improved disease control. Biologic drugs have also driven the growth of the market.
  • Oral Medications: The introduction of oral treatments for Crohn's disease is revolutionizing patient care by offering more convenient options. Drugs like JAK inhibitors, which can be taken orally, reduce the need for injections, improving patient compliance and quality of life. This trend is likely to drive market growth, especially among patients seeking more manageable treatment regimens.
  • Personalized Medicine: Precision medicine is an emerging trend that tailors treatments based on a patient's genetic profile and disease characteristics. By identifying specific biomarkers, doctors can personalize treatments for Crohn's disease, leading to better outcomes and fewer side effects. This approach has the potential to significantly impact treatment regimens for Crohn's disease.
  • Biosimilars: With the growing use of biologics, the development of biosimilars has emerged as a cost-effective solution for managing Crohn's disease. These alternatives to branded biologics are more affordable and are expected to improve access to high-quality treatments for patients, particularly in emerging markets with limited healthcare budgets.
  • Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring are gaining traction in the Crohn's disease treatment market. These technologies enable healthcare providers to track patient symptoms and treatment adherence from a distance, improving the management of the disease. Telemedicine allows for better follow-up care and timely adjustments to treatment regimens, enhancing patient outcomes.

Emerging trends such as biologic therapies, oral medications, personalized medicine, biosimilars, and telemedicine are driving significant changes in the Crohn's disease treatment drug market. These innovations are enhancing treatment options, improving patient outcomes, and expanding access to care, reshaping how Crohn's disease is managed globally.

Recent Developments in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market has seen notable developments in recent years, driven by innovations in biologics, oral therapies, and diagnostic techniques. These developments have contributed to more effective disease management and offer significant opportunities for both patients and pharmaceutical companies.

  • Approval of New Biologic Therapies: Several new biologic drugs have been approved for Crohn's disease, offering more targeted and effective treatments for patients with moderate-to-severe disease. These drugs work by targeting specific inflammatory pathways, resulting in better disease control and fewer side effects compared to traditional therapies.
  • Introduction of Oral JAK Inhibitors: The approval and introduction of oral Janus kinase (JAK) inhibitors for Crohn's disease have been a game-changer in the treatment landscape. These oral medications offer an alternative to injectable biologics, making treatment easier and more convenient for patients, thus improving adherence and overall treatment outcomes.
  • Biosimilars and Cost Reduction: The development of biosimilars has made biologic treatments more affordable, leading to greater accessibility for patients. The introduction of biosimilars is helping to expand the market for Crohn's disease treatments by reducing the cost burden and allowing more patients to benefit from biologic therapies.
  • Advanced Diagnostic Tools: New diagnostic tools, such as biomarkers and advanced imaging techniques, are improving the diagnosis and monitoring of Crohn's disease. These advancements allow for earlier detection and more accurate monitoring of disease progression, leading to better treatment outcomes and personalized care.
  • Focus on Personalized Medicine: Personalized medicine, which tailors treatments to an individual's genetic makeup and disease profile, is gaining momentum in the management of Crohn's disease. The use of genetic testing to guide treatment decisions is expected to improve therapeutic outcomes and reduce side effects, as therapies are better matched to the patient's specific needs.

The recent developments in the Crohn's disease treatment drug market, including new biologic therapies, oral JAK inhibitors, biosimilars, advanced diagnostics, and personalized medicine, are reshaping the treatment landscape. These innovations are improving patient care and offering more targeted, convenient, and cost-effective options for managing Crohn's disease.

Strategic Growth Opportunities in the Crohn's Disease Treatment Drug Market

The Crohn's disease treatment drug market presents several strategic growth opportunities, particularly through innovations in biologic therapies, oral medications, and emerging markets. Pharmaceutical companies are looking to expand their portfolios and reach new patient populations by addressing unmet medical needs in Crohn's disease treatment.

  • Expansion of Biologic Therapies: As biologic therapies continue to show strong efficacy in treating Crohn's disease, there is significant growth potential in developing and marketing new biologics. Companies can capitalize on this opportunity by exploring new targets in immune pathways to develop next-generation therapies that provide even better outcomes for patients.
  • Biosimilars: The biosimilars market is growing, and this is a cost-effective opportunity in the Crohn's disease treatment market. Pharmaceutical companies can take advantage of the patent expiration of biologics to develop biosimilars, thereby improving patient access to treatment and expanding the market in both developed and emerging regions.
  • Introduction of Oral Treatment Options: The shift toward oral treatments for Crohn's disease presents a strategic growth opportunity for pharmaceutical companies. With oral JAK inhibitors and other innovative treatments, companies can offer more convenient therapies that improve patient adherence, leading to increased market share and patient satisfaction.
  • Expanding into Emerging Markets: With the increasing prevalence of Crohn's disease in emerging markets like China and India, there is a significant opportunity to expand treatment access. Pharmaceutical companies can capitalize on this by introducing affordable therapies and leveraging local partnerships to improve the availability of Crohn's disease treatments.
  • Personalized Medicine and Genetic Testing: Personalized medicine offers an exciting growth opportunity by tailoring treatments based on genetic profiling. Pharmaceutical companies can invest in genetic testing platforms and companion diagnostics to optimize treatment regimens for Crohn's disease, providing more effective and individualized care.

Strategic growth opportunities in the Crohn's disease treatment drug market lie in biologics, biosimilars, oral therapies, expanding into emerging markets, and embracing personalized medicine. These opportunities provide companies with avenues to innovate, enhance patient care, and tap into new patient populations, driving growth in the market.

Crohn's Disease Treatment Drug Market Driver and Challenges

The Crohn's disease treatment drug market is influenced by various drivers and challenges, including advancements in medical technology, patient access, and regulatory dynamics. Understanding these factors is essential for stakeholders aiming to navigate the market's evolving landscape.

The factors responsible for driving the Crohn's disease treatment drug market include:

1. Technological Advancements in Biologic Therapies: Advances in biologic therapies, including monoclonal antibodies and anti-TNF agents, have significantly improved the treatment of Crohn's disease. These innovations allow for more targeted treatment, reducing inflammation and enhancing patient outcomes.

2. Increasing Awareness of Crohn's Disease: Growing awareness of Crohn's disease, both among patients and healthcare providers, is driving demand for new treatments. Early diagnosis and intervention are becoming more common, leading to improved patient care and greater use of advanced therapies.

3. Government and Healthcare Investments: Governments and healthcare organizations are increasingly investing in the treatment of chronic conditions like Crohn's disease. These investments support research and the availability of effective medications, helping to drive market growth and improve patient access to therapies.

4. Rising Prevalence of Crohn's Disease: The rising prevalence of Crohn's disease globally is increasing the demand for effective treatments. This trend is pushing pharmaceutical companies to develop new therapies and expand their portfolios to meet the needs of a growing patient population.

5. Regulatory Support for Drug Approvals: Favorable regulatory environments, especially in developed countries like the U.S. and Germany, are expediting the approval process for new Crohn's disease treatments. Faster approvals are allowing innovative therapies to reach the market sooner, benefiting patients in need.

Challenges in the Crohn's disease treatment drug market are:

1. High Treatment Costs: The high cost of biologics and advanced therapies remains a significant challenge, particularly for patients in low-income regions. The cost of these treatments can limit access to care and slow market growth.

2. Access to Treatment in Developing Regions: Limited access to treatment in developing regions, especially for advanced therapies like biologics, poses a challenge. This is due to both financial barriers and a lack of healthcare infrastructure.

3. Side Effects and Treatment Resistance: Some patients experience side effects from biologic therapies, and in some cases, they may develop resistance to these treatments. Managing these side effects and finding alternative therapies is an ongoing challenge.

The drivers, including technological advancements, increased awareness, and regulatory support, are fueling the growth of the Crohn's disease treatment drug market. However, challenges such as high costs, limited access to treatment, and side effects need to be addressed to fully optimize market potential.

List of Crohn's Disease Treatment Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, Crohn's disease treatment drug companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the Crohn's disease treatment drug companies profiled in this report include:

  • Biogen
  • UCB
  • Boehringer
  • AstraZeneca
  • AbbVie

Crohn's Disease Treatment Drug Market by Segment

The study includes a forecast for the global Crohn's disease treatment drug market by type, application, and region.

Crohn's Disease Treatment Drug Market by Type [Value from 2019 to 2031]:

  • Aminosalicylates
  • Corticosteroids
  • Immunomodulators
  • Antibiotics

Crohn's Disease Treatment Drug Market by Application [Value from 2019 to 2031]:

  • Small Intestine
  • Large Intestine

Crohn's Disease Treatment Drug Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Crohn's Disease Treatment Drug Market

The Crohn's Disease Treatment Drug market is dynamic with significant strides in medication and therapies to handle this chronic inflammatory bowel disease. As the cases of Crohn's disease grow worldwide, nations such as the United States, China, Germany, India, and Japan have made progress toward better treatment alternatives, which eventually led to successful patient outcomes and further growth of the market.

  • United States: The United States is the leader in Crohn's disease management, with continually increased application of biologic therapies like anti-TNF and anti-integrin antibodies. Novel drugs, including oral agents and Janus kinase (JAK) inhibitors, were recently approved to advance disease management. The emphasis will gradually shift towards personalized medicine that adapts the effectiveness of treatment according to genetic markers.
  • China: The market for treating Crohn's disease in China is growing in line with rising awareness and enhanced healthcare systems. Biologic treatments are becoming increasingly available, even though the costs are still quite high for many patients. Companies in the local pharmaceutical industry have been concentrating their efforts on manufacturing biosimilars, a move that should make biologics more accessible and increase patient access to a wider population of patients.
  • Germany: Germany has seen an increase in the adoption of biologic treatments and a focus on advanced therapies for Crohn's disease. The government's strong support for healthcare innovation and reimbursement policies ensures that patients have access to the latest therapies. There is also a growing emphasis on telemedicine and remote monitoring to improve patient adherence to treatments.
  • India: While in India, the Crohn's disease treatment market is obviously growing, access in certain areas is basically limited to leading-edge therapies. The awareness of Crohn's disease and its treatments is therefore increased, and above all, the government has been implementing policies in favor of improved access to healthcare. The private sector also is expanding the availability of biologics and immunosuppressive drugs.
  • Japan: Japan has been expanding its Crohn's disease treatment options, with increasing use of biologics like adalimumab and infliximab. In addition to biologics, Japan has introduced newer oral medications for inflammatory bowel diseases, offering more convenience for patients. The country is also emphasizing the development of precision medicine and the use of genetic testing to guide treatment choices.

Features of the Global Crohn's Disease Treatment Drug Market

  • Market Size Estimates: Crohn's disease treatment drug market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Crohn's disease treatment drug market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Crohn's disease treatment drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the Crohn's disease treatment drug market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Crohn's disease treatment drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the Crohn's disease treatment drug market by type (aminosalicylates, corticosteroids, immunomodulators, and antibiotics), application (small intestine and large intestine), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Crohn'S Disease Treatment Drug Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Aminosalicylates: Trends and Forecast (2019-2031)
  • 4.4 Corticosteroids: Trends and Forecast (2019-2031)
  • 4.5 Immunomodulators: Trends and Forecast (2019-2031)
  • 4.6 Antibiotics: Trends and Forecast (2019-2031)

5. Global Crohn'S Disease Treatment Drug Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Small Intestine: Trends and Forecast (2019-2031)
  • 5.4 Large Intestine: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Crohn'S Disease Treatment Drug Market by Region

7. North American Crohn'S Disease Treatment Drug Market

  • 7.1 Overview
  • 7.2 North American Crohn'S Disease Treatment Drug Market by Type
  • 7.3 North American Crohn'S Disease Treatment Drug Market by Application
  • 7.4 United States Crohn'S Disease Treatment Drug Market
  • 7.5 Mexican Crohn'S Disease Treatment Drug Market
  • 7.6 Canadian Crohn'S Disease Treatment Drug Market

8. European Crohn'S Disease Treatment Drug Market

  • 8.1 Overview
  • 8.2 European Crohn'S Disease Treatment Drug Market by Type
  • 8.3 European Crohn'S Disease Treatment Drug Market by Application
  • 8.4 German Crohn'S Disease Treatment Drug Market
  • 8.5 French Crohn'S Disease Treatment Drug Market
  • 8.6 Spanish Crohn'S Disease Treatment Drug Market
  • 8.7 Italian Crohn'S Disease Treatment Drug Market
  • 8.8 United Kingdom Crohn'S Disease Treatment Drug Market

9. APAC Crohn'S Disease Treatment Drug Market

  • 9.1 Overview
  • 9.2 APAC Crohn'S Disease Treatment Drug Market by Type
  • 9.3 APAC Crohn'S Disease Treatment Drug Market by Application
  • 9.4 Japanese Crohn'S Disease Treatment Drug Market
  • 9.5 Indian Crohn'S Disease Treatment Drug Market
  • 9.6 Chinese Crohn'S Disease Treatment Drug Market
  • 9.7 South Korean Crohn'S Disease Treatment Drug Market
  • 9.8 Indonesian Crohn'S Disease Treatment Drug Market

10. ROW Crohn'S Disease Treatment Drug Market

  • 10.1 Overview
  • 10.2 ROW Crohn'S Disease Treatment Drug Market by Type
  • 10.3 ROW Crohn'S Disease Treatment Drug Market by Application
  • 10.4 Middle Eastern Crohn'S Disease Treatment Drug Market
  • 10.5 South American Crohn'S Disease Treatment Drug Market
  • 10.6 African Crohn'S Disease Treatment Drug Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Crohn'S Disease Treatment Drug Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Biogen
    • Company Overview
    • Crohn'S Disease Treatment Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 UCB
    • Company Overview
    • Crohn'S Disease Treatment Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Boehringer
    • Company Overview
    • Crohn'S Disease Treatment Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 AstraZeneca
    • Company Overview
    • Crohn'S Disease Treatment Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 AbbVie
    • Company Overview
    • Crohn'S Disease Treatment Drug Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Crohn'S Disease Treatment Drug Market
  • Figure 2.1: Usage of Crohn'S Disease Treatment Drug Market
  • Figure 2.2: Classification of the Global Crohn'S Disease Treatment Drug Market
  • Figure 2.3: Supply Chain of the Global Crohn'S Disease Treatment Drug Market
  • Figure 2.4: Driver and Challenges of the Crohn'S Disease Treatment Drug Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Type
  • Figure 4.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 4.7: Trends and Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 5.1: Global Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Application
  • Figure 5.3: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 6.1: Trends of the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Crohn'S Disease Treatment Drug Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 7.2: North American Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 8.2: European Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
  • Figure 8.5: European Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 9.2: APAC Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Crohn'S Disease Treatment Drug Market (2019-2031)
  • Figure 10.2: ROW Crohn'S Disease Treatment Drug Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Crohn'S Disease Treatment Drug Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Crohn'S Disease Treatment Drug Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Crohn'S Disease Treatment Drug Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Crohn'S Disease Treatment Drug Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Type
  • Figure 12.2: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Application
  • Figure 12.3: Growth Opportunities for the Global Crohn'S Disease Treatment Drug Market by Region
  • Figure 12.4: Emerging Trends in the Global Crohn'S Disease Treatment Drug Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Crohn'S Disease Treatment Drug Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Crohn'S Disease Treatment Drug Market by Region
  • Table 1.3: Global Crohn'S Disease Treatment Drug Market Parameters and Attributes
  • Table 3.1: Trends of the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 3.2: Forecast for the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 4.4: Trends of Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 4.5: Forecast for Aminosalicylates in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 4.6: Trends of Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 4.7: Forecast for Corticosteroids in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 4.8: Trends of Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 4.9: Forecast for Immunomodulators in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 4.10: Trends of Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 4.11: Forecast for Antibiotics in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Crohn'S Disease Treatment Drug Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 5.4: Trends of Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 5.5: Forecast for Small Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 5.6: Trends of Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 5.7: Forecast for Large Intestine in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 7.1: Trends of the North American Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 7.2: Forecast for the North American Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 8.1: Trends of the European Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 8.2: Forecast for the European Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 9.1: Trends of the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 9.2: Forecast for the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 10.1: Trends of the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 10.2: Forecast for the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Crohn'S Disease Treatment Drug Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Crohn'S Disease Treatment Drug Market (2019-2031)
  • Table 11.1: Product Mapping of Crohn'S Disease Treatment Drug Suppliers Based on Segments
  • Table 11.2: Operational Integration of Crohn'S Disease Treatment Drug Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Crohn'S Disease Treatment Drug Revenue
  • Table 12.1: New Product Launches by Major Crohn'S Disease Treatment Drug Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Crohn'S Disease Treatment Drug Market